Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heterogeneous-Nuclear Ribonucleoprotein K | 2 | 2024 | 15 | 1.100 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 2019 | 286 | 1.080 |
Why?
|
RNA-Binding Proteins | 3 | 2024 | 1898 | 1.010 |
Why?
|
Phase Transition | 1 | 2021 | 71 | 0.740 |
Why?
|
Organelles | 1 | 2021 | 266 | 0.640 |
Why?
|
Exons | 1 | 2024 | 2391 | 0.620 |
Why?
|
Colonic Neoplasms | 4 | 2019 | 2539 | 0.620 |
Why?
|
Histone Acetyltransferases | 1 | 2019 | 336 | 0.580 |
Why?
|
Gene Amplification | 1 | 2022 | 1089 | 0.560 |
Why?
|
Pancreatic Neoplasms | 7 | 2024 | 5368 | 0.560 |
Why?
|
Cytoplasm | 2 | 2021 | 1510 | 0.550 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2022 | 1136 | 0.540 |
Why?
|
RNA, Messenger | 4 | 2024 | 12794 | 0.520 |
Why?
|
Mitochondrial Proteins | 1 | 2022 | 976 | 0.510 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2022 | 8554 | 0.450 |
Why?
|
Carcinoma, Pancreatic Ductal | 5 | 2024 | 1728 | 0.440 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2019 | 1899 | 0.410 |
Why?
|
Histones | 2 | 2019 | 2580 | 0.370 |
Why?
|
Wnt1 Protein | 1 | 2010 | 121 | 0.340 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2805 | 0.330 |
Why?
|
RNA Stability | 2 | 2021 | 329 | 0.310 |
Why?
|
Nuclear Proteins | 2 | 2022 | 5799 | 0.290 |
Why?
|
Chromogranins | 3 | 2023 | 161 | 0.280 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2023 | 1745 | 0.260 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 3 | 2023 | 195 | 0.260 |
Why?
|
DNA Helicases | 1 | 2011 | 851 | 0.260 |
Why?
|
Herpesvirus 1, Human | 2 | 2021 | 753 | 0.250 |
Why?
|
Neoplasms | 4 | 2022 | 22173 | 0.250 |
Why?
|
HeLa Cells | 4 | 2024 | 3094 | 0.240 |
Why?
|
RNA Nucleotidyltransferases | 1 | 2024 | 62 | 0.240 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2024 | 73 | 0.230 |
Why?
|
Polyadenylation | 1 | 2024 | 117 | 0.220 |
Why?
|
Cell Line, Tumor | 8 | 2022 | 16990 | 0.220 |
Why?
|
Methylation | 2 | 2019 | 1084 | 0.210 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2022 | 2917 | 0.200 |
Why?
|
Membrane Proteins | 1 | 2019 | 7859 | 0.200 |
Why?
|
Drosophila | 1 | 2010 | 1495 | 0.200 |
Why?
|
Cell Proliferation | 5 | 2019 | 10451 | 0.200 |
Why?
|
Introns | 1 | 2024 | 981 | 0.190 |
Why?
|
Carrier Proteins | 2 | 2013 | 4937 | 0.190 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2021 | 69 | 0.190 |
Why?
|
Transcription Factors | 3 | 2011 | 12130 | 0.190 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2021 | 24 | 0.190 |
Why?
|
Drosophila Proteins | 1 | 2010 | 1699 | 0.180 |
Why?
|
RNA Helicases | 1 | 2021 | 144 | 0.180 |
Why?
|
Eukaryotic Cells | 1 | 2021 | 195 | 0.170 |
Why?
|
Vitreous Body | 1 | 2021 | 399 | 0.160 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2020 | 203 | 0.160 |
Why?
|
Ubiquitination | 2 | 2016 | 1007 | 0.160 |
Why?
|
Lipid Bilayers | 1 | 2021 | 383 | 0.160 |
Why?
|
Interleukin-8 | 1 | 2021 | 696 | 0.150 |
Why?
|
Herpes Simplex | 1 | 2021 | 478 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 815 | 0.150 |
Why?
|
Cell Survival | 2 | 2022 | 5791 | 0.140 |
Why?
|
Exosomes | 1 | 2022 | 424 | 0.140 |
Why?
|
Apoptosis | 3 | 2014 | 9490 | 0.140 |
Why?
|
Acetylation | 1 | 2019 | 1055 | 0.140 |
Why?
|
HEK293 Cells | 2 | 2024 | 4281 | 0.140 |
Why?
|
Up-Regulation | 3 | 2016 | 4125 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2020 | 3612 | 0.120 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 517 | 0.120 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2015 | 138 | 0.120 |
Why?
|
Cell Nucleus | 2 | 2021 | 2910 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 988 | 0.110 |
Why?
|
GATA6 Transcription Factor | 1 | 2014 | 50 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 785 | 0.110 |
Why?
|
Gene Knockdown Techniques | 3 | 2014 | 1612 | 0.110 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6075 | 0.100 |
Why?
|
Virus Replication | 1 | 2020 | 2435 | 0.100 |
Why?
|
RNA, Antisense | 1 | 2013 | 136 | 0.100 |
Why?
|
Peptide Hydrolases | 1 | 2015 | 624 | 0.100 |
Why?
|
Visual Acuity | 1 | 2021 | 2672 | 0.090 |
Why?
|
CA-19-9 Antigen | 2 | 2022 | 106 | 0.090 |
Why?
|
Lysine | 1 | 2016 | 993 | 0.090 |
Why?
|
Cell Fusion | 1 | 2011 | 294 | 0.090 |
Why?
|
Armadillo Domain Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
Humans | 26 | 2024 | 761596 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2725 | 0.090 |
Why?
|
HCT116 Cells | 1 | 2011 | 404 | 0.090 |
Why?
|
DNA Damage | 1 | 2020 | 2449 | 0.090 |
Why?
|
Cadherins | 1 | 2014 | 903 | 0.080 |
Why?
|
Peptides | 1 | 2021 | 4358 | 0.080 |
Why?
|
Salivary Glands | 1 | 2010 | 229 | 0.080 |
Why?
|
Larva | 1 | 2010 | 508 | 0.080 |
Why?
|
Glioblastoma | 2 | 2014 | 3483 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2011 | 718 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4399 | 0.070 |
Why?
|
Glycoproteins | 1 | 2015 | 2203 | 0.070 |
Why?
|
Protein Binding | 3 | 2021 | 9353 | 0.070 |
Why?
|
Prognosis | 3 | 2022 | 29629 | 0.070 |
Why?
|
Mutation | 5 | 2023 | 30053 | 0.070 |
Why?
|
beta Catenin | 1 | 2011 | 1040 | 0.070 |
Why?
|
Cell Cycle Proteins | 2 | 2015 | 3449 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1252 | 0.070 |
Why?
|
Tissue Distribution | 1 | 2010 | 2264 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2013 | 1626 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2872 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1351 | 0.060 |
Why?
|
Animals, Genetically Modified | 1 | 2010 | 1561 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2020 | 6214 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2827 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4415 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2021 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3801 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2014 | 9032 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2330 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2018 | 11530 | 0.050 |
Why?
|
Thiouridine | 1 | 2020 | 6 | 0.050 |
Why?
|
Bromouracil | 1 | 2020 | 2 | 0.050 |
Why?
|
Smad4 Protein | 1 | 2022 | 191 | 0.050 |
Why?
|
Animals | 7 | 2021 | 168475 | 0.050 |
Why?
|
Uridine | 1 | 2020 | 141 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 482 | 0.040 |
Why?
|
Signal Transduction | 3 | 2011 | 23447 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3597 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7396 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9177 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6032 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3816 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2022 | 811 | 0.040 |
Why?
|
Mice, Nude | 2 | 2014 | 3614 | 0.030 |
Why?
|
Hospitals, University | 1 | 2018 | 564 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4878 | 0.030 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2015 | 26 | 0.030 |
Why?
|
Critical Pathways | 1 | 2018 | 474 | 0.030 |
Why?
|
HT29 Cells | 1 | 2015 | 193 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11120 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22176 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2010 | 18966 | 0.030 |
Why?
|
Trypsin | 1 | 2015 | 495 | 0.030 |
Why?
|
DNA Replication | 1 | 2020 | 1418 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2013 | 286 | 0.020 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2046 | 0.020 |
Why?
|
Gene Products, env | 1 | 2011 | 250 | 0.020 |
Why?
|
Pregnancy Proteins | 1 | 2011 | 222 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4111 | 0.020 |
Why?
|
Trophoblasts | 1 | 2011 | 224 | 0.020 |
Why?
|
Mitosis | 1 | 2015 | 1188 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2014 | 719 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8466 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2016 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2013 | 459 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 855 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 3060 | 0.020 |
Why?
|
Aged | 4 | 2024 | 169310 | 0.020 |
Why?
|
Biological Transport | 1 | 2013 | 2091 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5035 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7581 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2013 | 1756 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 220921 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3605 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14665 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 944 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10090 | 0.020 |
Why?
|
Female | 6 | 2024 | 392705 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6131 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14417 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2832 | 0.020 |
Why?
|
Male | 5 | 2024 | 360846 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5790 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7968 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6345 | 0.010 |
Why?
|
Mice | 3 | 2014 | 81539 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13510 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80647 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 3617 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7593 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23996 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39106 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41495 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58984 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9610 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59260 | 0.010 |
Why?
|
Pregnancy | 1 | 2011 | 29890 | 0.010 |
Why?
|
Adult | 1 | 2020 | 221210 | 0.000 |
Why?
|
Concepts
(178)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_